Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |